Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread

  • Elisa Giannoni
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy
  • Maria Letizia Taddei
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy
  • Andrea Morandi
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy
  • Giuseppina Comito
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy
  • Maura Calvani
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy
  • Francesca Bianchini
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy
  • Barbara Richichi
    Department of Chemistry, University of Florence, 50019, Sesto Fiorentino, Italy
  • Giovanni Raugei
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy
  • Nicholas Wong
    Division of Nephrology, Department of Medicine, McMaster University, L8N4A6, Hamilton, Ontario, Canada
  • Damu Tang
    Division of Nephrology, Department of Medicine, McMaster University, L8N4A6, Hamilton, Ontario, Canada
  • Paola Chiarugi
    Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134, Florence, Italy

収録刊行物

  • Oncotarget

    Oncotarget 6 (27), 24061-24074, 2015-06-27

    Impact Journals, LLC

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ